| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H15Cl2NO |
| Molar mass | 272.17 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Clorgiline (INN), orclorgyline (BAN), is amonoamine oxidase inhibitor (MAOI) structurally related topargyline which is described as anantidepressant.[1][2] Specifically, it is anirreversible andselectiveinhibitor ofmonoamine oxidase A (MAO-A).[3] Clorgiline was never marketed,[1] but it has found use inscientific research.[4] It has been found to bind with highaffinity to theσ1 receptor (Ki = 3.2 nM)[3][5] and with very high affinity to theI2 imidazoline receptor (Ki = 40 pM).[6]
Unlikeselegiline, clorgiline does not appear to be amonoaminergic activity enhancer (MAE).[7][8][9][10]
Clorgiline is also amultidrug efflux pump inhibitor.[11] Holmeset al., 2012 reverseazole fungicide resistance using clorgiline, showing promise for its use inmultiple fungicide resistance.[11]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |